Find uplifting stories about heroes, innovations, and solutions
11469 results for "weight loss treatment"
A new, stronger version of the popular weight loss medication Wegovy just got FDA approval, giving more Americans access to potentially more effective obesity treatment. The approval came through a new fast-track program designed to speed up medicines that address major health priorities.
A new weight-loss pill from AstraZeneca helped trial participants lose nearly 12% of their body weight in just nine months, offering fresh hope in the race to make weight management easier. The tablet could soon give doctors and patients another powerful tool in fighting obesity.
A breakthrough study shows the diabetes drug semaglutide helps older adults lose significant weight safely while improving heart health. Nearly half of participants over 65 achieved at least 15% weight loss in just over a year.
New real-world data shows many patients who stop taking popular weight loss drugs like Wegovy and Zepbound don't quickly regain the weight they lost. The findings challenge earlier concerns that the benefits disappear when treatment ends.
A new experimental obesity treatment targeting three hormones has shown significant weight loss in early testing. The "triple-G" drug from Kailera offers fresh hope in the rapidly expanding field of weight management medicine.
A new obesity treatment from pharmaceutical company Boehringer has shown promising results, helping patients lose an average of 16.6% of their body weight in clinical trials. The breakthrough adds another tool to the growing arsenal of effective weight loss medications changing lives worldwide.
Two major clinical trials show people can maintain their weight loss by switching to lower doses or once-daily pills after initial treatment. The findings offer hope for tackling one of obesity care's biggest challenges: keeping weight off after losing it.
A pill-based weight loss medication achieved up to 12% body weight reduction in clinical trials, offering a more accessible alternative to injectable drugs like Ozempic. The oral drug could transform obesity treatment by eliminating needles, refrigeration, and high manufacturing costs.
Scientists discovered that two genes can help predict who will lose weight on popular obesity medications and who might experience side effects. The breakthrough could personalize treatment for millions seeking help with weight loss.
Scientists are testing a breakthrough obesity treatment that helps people lose up to a third of their body weight without sacrificing muscle mass. The triple-action drug retatrutide could solve one of the biggest problems with current weight-loss medications.
A new weight-loss pill that can be taken any time of day just won FDA approval, making treatment easier for millions of Americans. The once-daily tablet offers a needle-free alternative starting at $149 monthly.
Pfizer's experimental obesity drug could change weight loss treatment from 52 injections per year to just 12. The once-monthly therapy showed promising results while making long-term treatment far more convenient for patients.
A daily pill helped patients lose 16% of their body weight in 44 weeks, outperforming other oral medications in development. The breakthrough could make obesity treatment more accessible to millions who avoid injections.
People using GLP-1 weight loss medications may not need weekly injections forever. A new study shows many patients maintain their weight loss while spacing out doses to every two or even six weeks.
Two pharmaceutical giants just released the first truly effective weight loss pills after years of failed attempts. The new medications could make obesity treatment as easy as taking a daily tablet.
Scientists just solved one of medicine's biggest challenges: turning injectable weight loss drugs like Ozempic into pills that work just as well. The breakthrough could help millions who avoid needles and make life-changing treatments easier to access.
Scientists discovered that popular diabetes and weight-loss medications might fight depression by feeding helpful gut bacteria, not by acting on the brain directly. This breakthrough could lead to probiotic treatments for people battling both obesity and depression.
India is launching affordable generic versions of popular weight-loss drugs after a key patent expired, potentially helping millions worldwide access treatments that once cost hundreds of dollars monthly. Prices could drop from $236 to just $60 per month.
Millions of Americans now have a more convenient option for weight loss treatment. The FDA just approved Foundayo, a once-daily pill that ships Monday and costs as little as $25 a month with insurance.
Millions who avoid needles can now access a breakthrough weight loss medication in pill form. The FDA just approved oral semaglutide and a higher-dose option, making effective obesity treatment easier than ever.
Showing 20 of 11469